Corcept Therapeutics (CORT) Leases (2019 - 2026)

Corcept Therapeutics' Leases history runs 8 years deep, the most recent figure standing at $7.2 million for Q1 2026.

• In Q1 2026, Leases rose 39.81% year-over-year to $7.2 million; the TTM figure through Mar 2026 stood at $7.2 million (up 39.81% YoY), while the FY2025 annual figure was $4.6 million, down 13.92% from the prior year.
• Leases came in at $7.2 million for Q1 2026 at Corcept Therapeutics, up from $4.6 million in the prior quarter.
• In the past five years, Leases ranged from a high of $7.2 million in Q1 2026 to a low of $61000.0 in Q1 2024.
• A 5-year average of $3.1 million and a median of $2.8 million in 2022 frame the typical range for Leases.
• Across the five-year window, Leases slumped 89.62% in 2023 and jumped 8337.7% in 2025, its largest moves.
• Corcept Therapeutics' Leases stood at $1.1 million in 2022, then sank by 89.5% to $120000.0 in 2023, then surged by 4336.67% to $5.3 million in 2024, then declined by 13.92% to $4.6 million in 2025, then surged by 57.02% to $7.2 million in 2026.
• According to Business Quant data, Leases over the past three periods registered $7.2 million, $4.6 million, and $4.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison